EMBC EMBECTA CORP

embecta Announces Quarterly Cash Dividend

embecta Announces Quarterly Cash Dividend

PARSIPPANY, N.J., Aug. 08, 2023 (GLOBE NEWSWIRE) -- The Board of Directors of Embecta Corp. (“embecta”) (Nasdaq: EMBC) has declared a quarterly cash dividend of $0.15 for each issued and outstanding share of the Company’s common stock. The dividend is payable on September 13, 2023 to stockholders of record at the close of business on August 25, 2023.

About embecta

embecta is a global diabetes care company that is leveraging its nearly 100-year legacy in insulin delivery to empower people with diabetes to live their best life through innovative solutions, partnerships and the passion of approximately 2,000 employees around the globe. For more information, visit or follow our social channels on , , and .

Contacts:

MediaInvestors 
Christian GlazarPravesh Khandelwal
Sr. Director, Corporate CommunicationsVP, Head of Investor Relations
908-821-6922551-264-6547


EN
08/08/2023

Underlying

EMBCEMBECTA CORP

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on EMBECTA CORP

 PRESS RELEASE
Free
EMBC EMBECTA CORP

Embecta Corp. Reports First Quarter Fiscal 2026 Financial Results

Embecta Corp. Reports First Quarter Fiscal 2026 Financial Results PARSIPPANY, N.J., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, today reported first quarter fiscal 2026 financial results. Visit the company’s Investor Relations website at to view the detailed first quarter fiscal 2026 and investor presentation. The company will host a conference call and live audio webcast for analysts and investors at 8:00 a.m. ET today, February ...

February 5, 2026 1 EN
 PRESS RELEASE
Free
EMBC EMBECTA CORP

embecta Announces Quarterly Cash Dividend

embecta Announces Quarterly Cash Dividend PARSIPPANY, N.J., Feb. 05, 2026 (GLOBE NEWSWIRE) -- The Board of Directors of Embecta Corp. (“embecta”) (Nasdaq: EMBC) has declared a quarterly cash dividend of $0.15 for each issued and outstanding share of the Company’s common stock. The dividend is payable on March 17, 2026 to stockholders of record at the close of business on February 27, 2026. About embecta embecta is a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, helping to improve lives through innovative soluti...

February 5, 2026 1 EN
 PRESS RELEASE
Free
EMBC EMBECTA CORP

embecta to Report Fiscal First Quarter Financial Results

embecta to Report Fiscal First Quarter Financial Results PARSIPPANY, N.J., Jan. 22, 2026 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, will host a conference call to discuss its fiscal first quarter 2026 financial results, provide an operational update, and host a question and answer session, at 8:00 a.m. Eastern Time (ET) on Thursday, February 5, 2026. Those who would like to participate may access the live webcast , or access the teleconference . ...

January 22, 2026 1 EN
 PRESS RELEASE
Free
EMBC EMBECTA CORP

embecta to Participate at the J.P. Morgan 2026 Healthcare Conference

embecta to Participate at the J.P. Morgan 2026 Healthcare Conference PARSIPPANY, N.J., Dec. 18, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. (embecta) (Nasdaq: EMBC) today announced that management will present at the J.P. Morgan Healthcare Conference in San Francisco on Wednesday, January 14, 2026 at 2:15 p.m. PT / 5:15 p.m. ET. Audio webcasts of the presentations will be accessible under the “News & Events” section of the Company's investor relations website at . About embectaembecta is a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medica...

December 18, 2025 1 EN
 PRESS RELEASE
Free
EMBC EMBECTA CORP

Embecta Corp. Reports Fiscal 2025 Fourth Quarter and Full Year Financi...

Embecta Corp. Reports Fiscal 2025 Fourth Quarter and Full Year Financial Results; Provides Initial Fiscal Year 2026 Financial Guidance PARSIPPANY, N.J., Nov. 25, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta” or the "Company") (Nasdaq: EMBC), a global diabetes care company, today reported financial results for the three- and twelve-month periods ended September 30, 2025. "Our fourth quarter results were largely in line with our expectations, with revenue lower year over year due to several items we had previously anticipated, including the impact of advanced distributor ordering in th...

November 25, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch